Lipid composition in rats with nonischemic chronic heart failure.

Area of Science:

• Cardiovascular Science
• Metabolic Research
• Animal Models of Disease

Background:

• Nonischemic chronic heart failure (CHF) is a complex condition with poorly understood metabolic alterations.
• Dyslipidemia, characterized by abnormal blood lipid levels, is frequently observed in heart failure patients.
• Understanding lipid changes in heart failure is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To investigate the impact of nonischemic chronic heart failure on lipid profiles in a rat model.
• To characterize the changes in total cholesterol, low-density lipoproteins (LDL), and the atherogenicity index during different stages of heart failure.
• To assess the effect of exogenous cholesterol administration on lipid metabolism in this heart failure model.

Main Methods:

• Induction of nonischemic chronic heart failure in rats using the oleothorax model.
• Monitoring of plasma lipid concentrations, including total cholesterol and LDL, at various disease stages.
• Calculation of the atherogenicity index to assess cardiovascular risk.
• Oral administration of cholesterol to evaluate its impact on lipid profiles.

Main Results:

• Initial stages of heart failure were associated with increased total cholesterol (primarily LDL fraction) and a higher atherogenicity index.
• Severe stages of heart failure showed a decrease in plasma total cholesterol and LDL concentrations, along with a reduced atherogenicity index.
• Intragastric cholesterol administration had minimal impact on blood lipid composition, regardless of heart failure severity.

Conclusions:

• Nonischemic chronic heart failure significantly alters lipid metabolism, with distinct changes observed in early versus severe disease stages.
• The observed decrease in lipids during severe heart failure warrants further investigation into underlying mechanisms.
• Exogenous cholesterol does not appear to significantly influence the dyslipidemia associated with this heart failure model.